Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025

Group 1 - Lexicon Pharmaceuticals will participate in a fireside chat at the Leerink Partners Global Healthcare Conference 2025 on March 12 at 10:00 a.m. ET [1] - The event will be accessible live and as a replay on the company's website [1] Group 2 - Lexicon Pharmaceuticals is a biopharmaceutical company focused on pioneering medicines that transform patients' lives [2] - The company utilizes the Genome5000™ program to study nearly 5,000 genes, identifying over 100 protein targets with significant therapeutic potential [2] - Lexicon has advanced multiple medicines to market and has a pipeline of drug candidates in various stages of development for conditions such as heart failure, neuropathic pain, obesity, cardiology, and diabetes [2]